Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England

BACKGROUND: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and quetiapine immediate release (IR) prescribed to patients with a clinical diagnosis of schizophrenia, and/or manic episodes associated with bipolar disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Osborne, Vicki, Davies, Miranda, Evans, Alison, Shakir, Saad A. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476334/
https://www.ncbi.nlm.nih.gov/pubmed/32953041
http://dx.doi.org/10.1177/2045125320954616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476334/
https://www.ncbi.nlm.nih.gov/pubmed/32953041
http://dx.doi.org/10.1177/2045125320954616

Ejemplares similares